Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations-Reference-Cited by-同舟云学术

Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations

Published:2019-05-27 Issue:2 Volume:84 Page:255-263
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Nobre Carmen F.^ORCID,Newman Matthew J.^ORCID,DeLisa Anne,Newman Pauline

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03875-6.pdf

Reference55 articles.

1. Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by world health organization subtypes. CA Cancer J Clin 66(6):443–459

2. Ali S, Saven A (2018) Hairy cell leukemia. In: Wiernik PH, Dutcher JP, Gertz MA (eds) Neoplastic diseases of the blood. Springer, Cham, pp 132–152. https://doi.org/10.1007/978-3-319-64263-5_10

3. Flandrin G, Sigaux F, Sebahoun G, Bouffette P (1984) Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin Oncol 11(4 Suppl 2):458–471

4. Orsi L, Delabre L, Monnereau A et al (2009) Occupational exposure to pesticides and lymphoid neoplasms among men: results of a french case-control study. Occup Environ Med 66(5):291–298

5. Monnereau A, Slager SL, Hughes AM et al (2014) Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):115–124

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Therapeutic Mechanisms of Honey in Mitigating Toxicity from Anticancer Chemotherapy Toxicity: A Review;Journal of Xenobiotics;2024-08-20

2. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07

3. A high-throughput lysosome trafficking assay guides ligand selection and elucidates differences in CD22-targeted nanodelivery;Science and Technology of Advanced Materials;2024-05-29

4. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice;Experimental Hematology & Oncology;2024-03-01

5. Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform;Biologics;2024-02-23